Zymeworks (NASDAQ: ZYME) reported Q2 EPS of ($0.62), $0.25 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $4.6 million versus the consensus estimate of $19.1 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.